O	0	10	Regulation	Regulation	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	17	p53	p53	NN	B-NP
O	17	18	-	-	HYPH	B-NP
O	18	27	dependent	dependent	JJ	I-NP
O	28	37	apoptosis	apoptosis	NN	I-NP
O	37	38	,	,	,	O
O	39	54	transcriptional	transcriptional	JJ	B-NP
O	55	65	repression	repression	NN	I-NP
O	65	66	,	,	,	O
O	67	70	and	and	CC	O
B-Cell	71	75	cell	cell	NN	B-NP
O	76	90	transformation	transformation	NN	I-NP
O	91	93	by	by	IN	B-PP
O	94	109	phosphorylation	phosphorylation	NN	B-NP
O	110	112	of	of	IN	B-PP
O	113	116	the	the	DT	B-NP
O	117	119	55	55	CD	I-NP
O	119	120	-	-	HYPH	I-NP
O	120	130	kilodalton	kilodalton	NN	I-NP
O	131	134	E1B	E1B	NN	I-NP
O	135	142	protein	protein	NN	I-NP
O	143	145	of	of	IN	B-PP
O	146	151	human	human	JJ	B-NP
O	152	162	adenovirus	adenovirus	NN	I-NP
O	163	167	type	type	NN	I-NP
O	168	169	5	5	CD	I-NP
O	169	170	.	.	.	O

O	172	175	The	The	DT	B-NP
O	176	186	adenovirus	adenovirus	NN	I-NP
O	187	191	type	type	NN	I-NP
O	192	193	5	5	CD	I-NP
O	194	196	55	55	CD	I-NP
O	196	197	-	-	HYPH	I-NP
O	197	200	kDa	kDa	NN	I-NP
O	201	204	E1B	E1B	NN	I-NP
O	205	212	protein	protein	NN	I-NP
O	213	214	(	(	(	O
O	214	217	E1B	E1B	NN	B-NP
O	217	218	-	-	HYPH	B-NP
O	218	223	55kDa	55kDa	NN	I-NP
O	223	224	)	)	)	O
O	225	235	cooperates	cooperate	VBZ	B-VP
O	236	240	with	with	IN	B-PP
O	241	244	E1A	E1A	NN	B-NP
O	245	249	gene	gene	NN	I-NP
O	250	258	products	product	NNS	I-NP
O	259	261	to	to	TO	B-VP
O	262	268	induce	induce	VB	I-VP
B-Cell	269	273	cell	cell	NN	B-NP
O	274	288	transformation	transformation	NN	I-NP
O	288	289	.	.	.	O

O	290	293	E1A	E1A	NN	B-NP
O	294	302	proteins	protein	NNS	I-NP
O	303	312	stimulate	stimulate	VBP	B-VP
O	313	316	DNA	DNA	NN	B-NP
O	317	326	synthesis	synthesis	NN	I-NP
O	327	330	and	and	CC	O
B-Cell	331	335	cell	cell	NN	B-NP
O	336	349	proliferation	proliferation	NN	I-NP
O	349	350	;	;	:	O
O	351	358	however	however	RB	B-ADVP
O	358	359	,	,	,	O
O	360	364	they	they	PRP	B-NP
O	365	369	also	also	RB	B-ADVP
O	370	375	cause	cause	VBP	B-VP
O	376	381	rapid	rapid	JJ	B-NP
B-Cell	382	386	cell	cell	NN	I-NP
O	387	392	death	death	NN	I-NP
O	393	395	by	by	IN	B-PP
O	396	399	p53	p53	NN	B-NP
O	399	400	-	-	HYPH	B-NP
O	400	409	dependent	dependent	JJ	I-NP
O	410	413	and	and	CC	I-NP
O	414	417	p53	p53	NN	I-NP
O	417	418	-	-	HYPH	B-NP
O	418	429	independent	independent	JJ	I-NP
O	430	439	apoptosis	apoptosis	NN	I-NP
O	439	440	.	.	.	O

O	441	443	It	It	PRP	B-NP
O	444	446	is	be	VBZ	B-VP
O	447	455	believed	believe	VBN	I-VP
O	456	460	that	that	IN	B-SBAR
O	461	464	the	the	DT	B-NP
O	465	469	role	role	NN	I-NP
O	470	472	of	of	IN	B-PP
O	473	476	the	the	DT	B-NP
O	477	480	E1B	E1B	NN	I-NP
O	480	481	-	-	HYPH	B-NP
O	481	486	55kDa	55kDa	NN	I-NP
O	487	494	protein	protein	NN	I-NP
O	495	497	in	in	IN	B-PP
O	498	512	transformation	transformation	NN	B-NP
O	513	515	is	be	VBZ	B-VP
O	516	518	to	to	TO	B-VP
O	519	526	protect	protect	VB	I-VP
O	527	534	against	against	IN	B-PP
O	535	538	p53	p53	NN	B-NP
O	538	539	-	-	HYPH	B-NP
O	539	548	dependent	dependent	JJ	I-NP
O	549	558	apoptosis	apoptosis	NN	I-NP
O	559	561	by	by	IN	B-PP
O	562	569	binding	bind	VBG	B-VP
O	570	572	to	to	TO	B-PP
O	573	576	and	and	CC	O
O	577	589	inactivating	inactivate	VBG	B-VP
O	590	593	p53	p53	NN	B-NP
O	593	594	.	.	.	O

O	595	597	It	It	PRP	B-NP
O	598	601	has	have	VBZ	B-VP
O	602	606	been	be	VBN	I-VP
O	607	612	shown	show	VBN	I-VP
O	613	623	previously	previously	RB	B-ADVP
O	624	628	that	that	IN	B-SBAR
O	629	632	the	the	DT	B-NP
O	633	635	55	55	CD	I-NP
O	635	636	-	-	HYPH	I-NP
O	636	639	kDa	kDa	NN	I-NP
O	640	651	polypeptide	polypeptide	NN	I-NP
O	652	661	abrogates	abrogate	VBZ	B-VP
O	662	665	p53	p53	NN	B-NP
O	665	666	-	-	HYPH	O
O	666	674	mediated	mediate	VBN	B-NP
O	675	690	transactivation	transactivation	NN	I-NP
O	691	694	and	and	CC	O
O	695	699	that	that	IN	B-SBAR
O	700	707	mutants	mutant	NNS	B-NP
O	708	717	defective	defective	JJ	B-ADJP
O	718	720	in	in	IN	B-PP
O	721	724	p53	p53	NN	B-NP
O	725	732	binding	binding	NN	I-NP
O	733	736	are	be	VBP	B-VP
O	737	743	unable	unable	JJ	B-ADJP
O	744	746	to	to	TO	B-VP
O	747	756	cooperate	cooperate	VB	I-VP
O	757	761	with	with	IN	B-PP
O	762	765	E1A	E1A	NN	B-NP
O	766	768	in	in	IN	B-PP
O	769	783	transformation	transformation	NN	B-NP
O	783	784	.	.	.	O

O	785	787	We	We	PRP	B-NP
O	788	792	have	have	VBP	B-VP
O	793	803	previously	previously	RB	I-VP
O	804	810	mapped	map	VBN	I-VP
O	811	826	phosphorylation	phosphorylation	NN	B-NP
O	827	832	sites	site	NNS	I-NP
O	833	837	near	near	IN	B-PP
O	838	841	the	the	DT	B-NP
O	842	849	carboxy	carboxy	NN	I-NP
O	850	858	terminus	terminus	NN	I-NP
O	859	861	of	of	IN	B-PP
O	862	865	the	the	DT	B-NP
O	866	869	E1B	E1B	NN	I-NP
O	869	870	-	-	HYPH	B-NP
O	870	875	55kDa	55kDa	NN	I-NP
O	876	883	protein	protein	NN	I-NP
O	884	886	at	at	IN	B-PP
O	887	890	Ser	Ser	NN	B-NP
O	890	891	-	-	HYPH	B-NP
O	891	894	490	490	CD	I-NP
O	895	898	and	and	CC	I-NP
O	899	902	Ser	Ser	NN	I-NP
O	902	903	-	-	HYPH	B-NP
O	903	906	491	491	CD	I-NP
O	906	907	,	,	,	O
O	908	913	which	which	WDT	B-NP
O	914	917	lie	lie	VBP	B-VP
O	918	924	within	within	IN	B-PP
O	925	931	casein	casein	NN	B-NP
O	932	938	kinase	kinase	NN	I-NP
O	939	941	II	II	CD	I-NP
O	942	951	consensus	consensus	NN	I-NP
O	952	961	sequences	sequence	NNS	I-NP
O	961	962	.	.	.	O

O	963	973	Conversion	Conversion	NN	B-NP
O	974	976	of	of	IN	B-PP
O	977	982	these	these	DT	B-NP
O	983	988	sites	site	NNS	I-NP
O	989	991	to	to	TO	B-PP
O	992	999	alanine	alanine	NN	B-NP
O	1000	1008	residues	residue	NNS	I-NP
O	1009	1016	greatly	greatly	RB	B-ADVP
O	1017	1024	reduced	reduce	VBD	B-VP
O	1025	1037	transforming	transform	VBG	I-VP
O	1038	1046	activity	activity	NN	B-NP
O	1046	1047	,	,	,	O
O	1048	1051	and	and	CC	O
O	1052	1060	although	although	IN	B-SBAR
O	1061	1064	the	the	DT	B-NP
O	1065	1071	mutant	mutant	JJ	I-NP
O	1072	1074	55	55	CD	I-NP
O	1074	1075	-	-	HYPH	I-NP
O	1075	1078	kDa	kDa	NN	I-NP
O	1079	1086	protein	protein	NN	I-NP
O	1087	1090	was	be	VBD	B-VP
O	1091	1096	found	find	VBN	I-VP
O	1097	1099	to	to	TO	I-VP
O	1100	1108	interact	interact	VB	I-VP
O	1109	1113	with	with	IN	B-PP
O	1114	1117	p53	p53	NN	B-NP
O	1118	1120	at	at	IN	B-PP
O	1121	1127	normal	normal	JJ	B-NP
O	1128	1134	levels	level	NNS	I-NP
O	1134	1135	,	,	,	O
O	1136	1138	it	it	PRP	B-NP
O	1139	1142	was	be	VBD	B-VP
O	1143	1151	somewhat	somewhat	RB	B-ADJP
O	1152	1161	defective	defective	JJ	I-ADJP
O	1162	1165	for	for	IN	B-PP
O	1166	1177	suppression	suppression	NN	B-NP
O	1178	1180	of	of	IN	B-PP
O	1181	1184	p53	p53	NN	B-NP
O	1185	1200	transactivation	transactivation	NN	I-NP
O	1201	1209	activity	activity	NN	I-NP
O	1209	1210	.	.	.	O

O	1211	1213	We	We	PRP	B-NP
O	1214	1217	now	now	RB	B-ADVP
O	1218	1224	report	report	VBP	B-VP
O	1225	1229	that	that	IN	B-SBAR
O	1230	1231	a	a	DT	B-NP
O	1232	1238	nearby	nearby	JJ	I-NP
O	1239	1246	residue	residue	NN	I-NP
O	1246	1247	,	,	,	O
O	1248	1251	Thr	Thr	NN	B-NP
O	1251	1252	-	-	HYPH	O
O	1252	1255	495	495	CD	B-NP
O	1255	1256	,	,	,	O
O	1257	1261	also	also	RB	B-ADVP
O	1262	1269	appears	appear	VBZ	B-VP
O	1270	1272	to	to	TO	I-VP
O	1273	1275	be	be	VB	I-VP
O	1276	1290	phosphorylated	phosphorylate	VBN	I-VP
O	1290	1291	.	.	.	O

O	1292	1294	We	We	PRP	B-NP
O	1295	1306	demonstrate	demonstrate	VBP	B-VP
O	1307	1315	directly	directly	RB	B-ADVP
O	1316	1320	that	that	IN	B-SBAR
O	1321	1324	the	the	DT	B-NP
O	1325	1329	wild	wild	JJ	I-NP
O	1329	1330	-	-	HYPH	I-NP
O	1330	1334	type	type	NN	I-NP
O	1335	1337	55	55	CD	I-NP
O	1337	1338	-	-	HYPH	I-NP
O	1338	1341	kDa	kDa	NN	I-NP
O	1342	1349	protein	protein	NN	I-NP
O	1350	1352	is	be	VBZ	B-VP
O	1353	1357	able	able	JJ	B-ADJP
O	1358	1360	to	to	TO	B-VP
O	1361	1366	block	block	VB	I-VP
O	1367	1370	E1A	E1A	NN	B-NP
O	1370	1371	-	-	HYPH	O
O	1371	1378	induced	induce	VBN	B-NP
O	1379	1382	p53	p53	NN	I-NP
O	1382	1383	-	-	HYPH	B-NP
O	1383	1392	dependent	dependent	JJ	I-NP
O	1393	1402	apoptosis	apoptosis	NN	I-NP
O	1402	1403	,	,	,	O
O	1404	1411	whereas	whereas	IN	O
B-Cell	1412	1417	cells	cell	NNS	B-NP
O	1418	1426	infected	infect	VBN	B-VP
O	1427	1429	by	by	IN	B-PP
O	1430	1436	mutant	mutant	JJ	B-NP
O	1437	1442	pm490	pm490	NN	I-NP
O	1442	1443	/	/	SYM	B-NP
O	1443	1444	1	1	CD	I-NP
O	1444	1445	/	/	SYM	I-NP
O	1445	1447	5A	5A	NN	I-NP
O	1447	1448	,	,	,	O
O	1449	1454	which	which	WDT	B-NP
O	1455	1463	contains	contain	VBZ	B-VP
O	1464	1471	alanine	alanine	NN	B-NP
O	1472	1480	residues	residue	NNS	I-NP
O	1481	1483	at	at	IN	B-PP
O	1484	1487	all	all	DT	B-NP
O	1488	1493	three	three	CD	I-NP
O	1494	1509	phosphorylation	phosphorylation	NN	I-NP
O	1510	1515	sites	site	NNS	I-NP
O	1515	1516	,	,	,	O
O	1517	1526	exhibited	exhibit	VBD	B-VP
O	1527	1536	extensive	extensive	JJ	B-NP
O	1537	1540	DNA	DNA	NN	I-NP
O	1541	1554	fragmentation	fragmentation	NN	I-NP
O	1555	1558	and	and	CC	O
O	1559	1566	classic	classic	JJ	B-NP
O	1567	1576	apoptotic	apoptotic	JJ	I-NP
B-Cell	1577	1581	cell	cell	NN	I-NP
O	1582	1587	death	death	NN	I-NP
O	1587	1588	.	.	.	O

O	1589	1592	The	The	DT	B-NP
O	1593	1596	E1B	E1B	NN	I-NP
O	1596	1597	-	-	HYPH	I-NP
O	1597	1602	55kDa	55kDa	NN	I-NP
O	1603	1610	product	product	NN	I-NP
O	1611	1614	has	have	VBZ	B-VP
O	1615	1619	been	be	VBN	I-VP
O	1620	1625	shown	show	VBN	I-VP
O	1626	1628	to	to	TO	I-VP
O	1629	1636	exhibit	exhibit	VB	I-VP
O	1637	1646	intrinsic	intrinsic	JJ	B-NP
O	1647	1662	transcriptional	transcriptional	JJ	I-NP
O	1663	1673	repression	repression	NN	I-NP
O	1674	1682	activity	activity	NN	I-NP
O	1683	1687	when	when	WRB	B-ADVP
O	1688	1697	localized	localized	JJ	B-ADJP
O	1698	1700	to	to	TO	B-PP
O	1701	1710	promoters	promoter	NNS	B-NP
O	1710	1711	,	,	,	O
O	1712	1716	such	such	JJ	B-PP
O	1717	1719	as	as	IN	I-PP
O	1720	1722	by	by	IN	B-PP
O	1723	1729	fusion	fusion	NN	B-NP
O	1730	1734	with	with	IN	B-PP
O	1735	1738	the	the	DT	B-NP
O	1739	1743	GAL4	GAL4	NN	I-NP
O	1744	1747	DNA	DNA	NN	I-NP
O	1747	1748	-	-	HYPH	O
O	1748	1755	binding	bind	VBG	B-NP
O	1756	1762	domain	domain	NN	I-NP
O	1762	1763	,	,	,	O
O	1764	1768	even	even	RB	B-ADVP
O	1769	1771	in	in	IN	B-PP
O	1772	1775	the	the	DT	B-NP
O	1776	1783	absence	absence	NN	I-NP
O	1784	1786	of	of	IN	B-PP
O	1787	1790	p53	p53	NN	B-NP
O	1790	1791	.	.	.	O

O	1792	1796	Such	Such	JJ	B-NP
O	1797	1807	repression	repression	NN	I-NP
O	1808	1816	activity	activity	NN	I-NP
O	1817	1820	was	be	VBD	B-VP
O	1821	1828	totally	totally	RB	B-ADJP
O	1829	1835	absent	absent	JJ	I-ADJP
O	1836	1840	with	with	IN	B-PP
O	1841	1847	mutant	mutant	JJ	B-NP
O	1848	1853	pm490	pm490	NN	I-NP
O	1853	1854	/	/	SYM	B-NP
O	1854	1855	1	1	CD	I-NP
O	1855	1856	/	/	SYM	I-NP
O	1856	1858	5A	5A	NN	I-NP
O	1858	1859	.	.	.	O

O	1860	1865	These	These	DT	B-NP
O	1866	1870	data	datum	NNS	I-NP
O	1871	1880	suggested	suggest	VBD	B-VP
O	1881	1885	that	that	IN	B-SBAR
O	1886	1896	inhibition	inhibition	NN	B-NP
O	1897	1899	of	of	IN	B-PP
O	1900	1903	p53	p53	NN	B-NP
O	1903	1904	-	-	HYPH	B-NP
O	1904	1913	dependent	dependent	JJ	I-NP
O	1914	1923	apoptosis	apoptosis	NN	I-NP
O	1924	1927	may	may	MD	B-VP
O	1928	1934	depend	depend	VB	I-VP
O	1935	1937	on	on	IN	B-PP
O	1938	1941	the	the	DT	B-NP
O	1942	1957	transcriptional	transcriptional	JJ	I-NP
O	1958	1968	repression	repression	NN	I-NP
O	1969	1977	function	function	NN	I-NP
O	1978	1980	of	of	IN	B-PP
O	1981	1984	the	the	DT	B-NP
O	1985	1987	55	55	CD	I-NP
O	1987	1988	-	-	HYPH	I-NP
O	1988	1991	kDa	kDa	NN	I-NP
O	1992	1999	protein	protein	NN	I-NP
O	1999	2000	,	,	,	O
O	2001	2006	which	which	WDT	B-NP
O	2007	2014	appears	appear	VBZ	B-VP
O	2015	2017	to	to	TO	I-VP
O	2018	2020	be	be	VB	I-VP
O	2021	2030	regulated	regulate	VBN	I-VP
O	2031	2033	be	be	VB	B-VP
O	2034	2049	phosphorylation	phosphorylation	NN	B-NP
O	2050	2052	at	at	IN	B-PP
O	2053	2056	the	the	DT	B-NP
O	2057	2064	carboxy	carboxy	NN	I-NP
O	2065	2073	terminus	terminus	NN	I-NP
O	2073	2074	.	.	.	O

